CLINICAL_TRIALS
trial_result
· 2021-02-25
Clinical Trial Update: Efficacy and Safety of Atacicept in IgA Nephropathy [Phase 2]
Summary
Phase 2 trial of atacicept in IgA nephropathy was terminated with posted results in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: IgA Nephropathy | Phase 2 | Status: TERMINATED | Results posted: 2021-02-25